HRTX

Heron Therapeutics Inc.

Price

$0.33

return (12m)

-76.37%

p/e

-1.80

p/bv

8.88

DIVIDEND YIELD

0.00%

HRTX price

Heron Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment HRTX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-36.47%

3 months

-62.25%

1 year

-76.37%

2 years

-82.98%

5 years

-97.18%

10 years

-98.23%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals HRTX

Valuation

P/E

-1.80

Sector -4.26

Industry -4.26

P/BV

8.88

Sector 2.11

Industry 2.11

P/Revenue (PSR)

0.41

Sector 2.08

Industry 2.08

EV/EBITDA

Sector -546.19

Industry -546.19

EV/EBIT

Sector -37.31

Industry -37.31

P/EBITDA

Sector -50.76

Industry -50.76

P/EBIT

Sector -39.62

Industry -39.62

P/Total Assets

0.24

Sector 1.25

Industry 1.25

P/Net Current Assets

-3.95

Sector -5.47

Industry -5.47

P/Working Capital

0.45

Sector -1.10

Industry -1.10

EPS

-0.18

Sector -1.94

Industry -1.94

BVPS

0.04

Sector 1.89

Industry 1.89

Efficiency

Gross Margin

70.07%

Sector 38.90%

Industry 38.90%

EBITDA Margin

0.00%

Sector -13,872.56%

Industry -13,872.56%

EBIT Margin

0.00%

Sector -4,253,834.43%

Industry -4,253,834.43%

Operating Margin

-7.18%

Sector -36.74%

Industry -36.74%

Net Profit Margins

-22.52%

Sector -37.51%

Industry -37.51%

Asset Turnover

0.15

Sector 0.03

Industry 0.03

Profitability

ROE

-492.76%

Sector -61.50%

Industry -61.50%

ROA

-13.50%

Sector -63.85%

Industry -63.85%

ROIC

0.00%

Sector -498.30%

Industry -498.30%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

2.49

Sector 2.89

Industry 2.89

Net Debt / EBITDA

Sector -39,048,222.71

Industry -39,048,222.71

Net Debt / EBIT

Sector -10.24

Industry -10.24

Net Debt / Equity

15.73

Sector -0.60

Industry -0.60

Gross Debt / Equity

15.73

Sector -0.83

Industry -0.83

Equity/Assets

0.03

Sector 0.43

Industry 0.43

Liabilities/Assets

0.97

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

11.85%

Sector -

Industry -

5Y Earnings CAGR

-31.19%

Sector -

Industry -

Fundamentals HRTX

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
HRTX Heron Therapeutics Inc.	$0.33	-75.85%	0.00%	-1.80	8.88	-492.76%	-22.52%
JNJ Johnson & Johnson	$266.50	55.29%	1.93%	31.09	7.70	24.76%	21.48%
PFE Pfizer Inc.	$27.87	21.03%	6.26%	35.86	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$256.91	27.42%	2.58%	74.16	-78.93	-106.44%	9.81%
NVO Novo Nordisk A/S	$45.62	-14.65%	3.95%	11.47	6.09	53.11%	35.32%
MRK Merck & Co. Inc.	$147.77	82.61%	2.24%	116.78	8.81	7.55%	4.76%
AZN AstraZeneca PLC	$161.98	3.71%	1.93%	24.59	5.10	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$66.29	45.78%	3.73%	14.81	6.16	41.55%	18.85%
ZTS Zoetis Inc.	$76.84	-49.43%	2.67%	12.20	10.25	84.02%	27.77%
REGN Regeneron Pharmaceuticals Inc.	$792.43	37.47%	0.44%	19.71	2.69	13.65%	27.86%
AMGN Amgen Inc.	$432.42	55.55%	2.22%	27.25	20.39	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$105.00	43.48%	0.00%	30.73	88.55	288.14%	24.86%
MCK McKesson Corporation	$897.16	31.93%	0.38%	19.60	-26.88	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$542.40	39.41%	0.00%	31.57	6.87	21.76%	35.00%
CAH Cardinal Health Inc.	$235.19	59.60%	0.88%	35.20	-20.39	-57.93%	0.62%
HRMY Harmony Biosciences Holdings Inc.	$39.29	3.26%	0.00%	12.32	2.23	18.14%	18.89%
BIIB Biogen Inc.	$217.24	59.31%	0.00%	38.68	1.71	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

HRTX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Heron Therapeutics

Heron Therapeutics Inc.

Average Investor10 user rating

4.0 (1 people)

United States

43 years

Founded: 1983

1987

Time since IPO - 39 years

231

Employees

Heron Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $61.33 million, with shareholders equity totaling $6.91 million.

The company employs approximately 231 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Heron Therapeutics Inc. reported $151.18 million in revenue, generating net income of $-34.05 million.

Key financial metrics include a P/E ratio of -1.80, a price-to-book (P/B) ratio of 8.88, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker HRTX.

Market cap

$61.33 million

Net worth

$6.91 million

$6,910,000.00

Assets

$252.26 million

$252,260,000.00

Total Shares Outstanding

190.00 million

190,000,000

Average Daily Trading Volume

$3.05 million

$3,046,005.60

Sector

Health Care

Industry

Biotechnology

HRTX

HRTX revenue and profits

Financial Results HRTX

DRAG THE FRAME TO SEE MORE DATA

HRTX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$897.16 31,33% (12M)

P/E

19.60

0.38%

ROE

-137.16%

P/BV

-26.88

CAH - Cardinal Health

$235.19 60,10% (12M)

P/E

35.20

0.88%

ROE

-57.93%

P/BV

-20.39

JNJ - Johnson & Johnson

$266.50 54,96% (12M)

P/E

31.09

1.93%

ROE

24.76%

P/BV

7.70

ABBV - AbbVie

$256.91 26,00% (12M)

P/E

74.16

2.58%

ROE

-106.44%

P/BV

-78.93

MRK - Merck & Co.

$147.77 82,50% (12M)

P/E

116.78

2.24%

ROE

7.55%

P/BV

8.81

AZN - AstraZeneca

$161.98 3,46% (12M)

P/E

24.59

1.93%

ROE

20.74%

P/BV

5.10

PFE - Pfizer

$27.87 22,54% (12M)

P/E

35.86

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$897.16 31,33% (12 M)

P/L

19.60

0.38%

ROE

-137.16%

P/VP

-26.88

CAH - Cardinal Health

$235.19 60,10% (12 M)

P/L

35.20

0.88%

ROE

-57.93%

P/VP

-20.39

JNJ - Johnson & Johnson

$266.50 54,96% (12 M)

P/L

31.09

1.93%

ROE

24.76%

P/VP

7.70

ABBV - AbbVie

$256.91 26,00% (12 M)

P/L

74.16

2.58%

ROE

-106.44%

P/VP

-78.93

MRK - Merck & Co.

$147.77 82,50% (12 M)

P/L

116.78

2.24%

ROE

7.55%

P/VP

8.81

AZN - AstraZeneca

$161.98 3,46% (12 M)

P/L

24.59

1.93%

ROE

20.74%

P/VP

5.10

PFE - Pfizer

$27.87 22,54% (12 M)

P/L

35.86

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Heron Therapeutics (HRTX) today?

A cotação de Heron Therapeutics (HRTX) hoje está em US$ 0.33, com uma variação de -76.37% em relação ao último ano. A cotação de Heron Therapeutics (HRTX) iniciou o ano negociando na casa dos US$ 1.30 e hoje está em US$ 0.33. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Heron Therapeutics (HRTX) e dados de ações do Ibovespa e mercados internacionais.

Quando Heron Therapeutics (HRTX) paga dividendos?

Heron Therapeutics (HRTX) não distribuiu dividendos no último ano.

Is Heron Therapeutics (HRTX) a good investment?

Atualmente, Heron Therapeutics (HRTX) está cotada a US$ 0.33, com um P/L de -1.80, representando um desvio de -710% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de -76.37 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de -76.37%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Heron Therapeutics (HRTX) stock?

Investir em ações de Heron Therapeutics (HRTX) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Heron Therapeutics (HRTX) yield today?

A rentabilidade de Heron Therapeutics (HRTX) foi de -36.47% no último mês, -76.37% no último ano e -97.18% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Heron Therapeutics (HRTX) hoje, o investimento total seria de US$ 32.85, com base na cotação atual de US$ 0.33.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 7.76
Em 5 anos: US$ 0.93
Em 10 anos: US$ 0.58

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

HRTX

Heron Therapeutics Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment HRTX

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING HRTX WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Heron Therapeutics

Heron Therapeutics Inc.

United States

43 years

1987

231

PROFIT X PRICE HRTX

Financial Results HRTX

HRTX cash flow

Asset, Revenue and Profit Growth - HRTX

HRTX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions